Egf Theramed Health Stock Cash Per Share

EVAHF Stock  USD 0.22  0.00  0.00%   
EGF Theramed Health fundamentals help investors to digest information that contributes to EGF Theramed's financial success or failures. It also enables traders to predict the movement of EGF Pink Sheet. The fundamental analysis module provides a way to measure EGF Theramed's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to EGF Theramed pink sheet.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

EGF Theramed Health Company Cash Per Share Analysis

EGF Theramed's Cash per Share is a ratio of current cash on hands or in the banks of the company to a total number of shares outstanding. It is used to determine a firm's liquidity and is a good indicator of the overall financial health of a company. Value investors often compare this ratio to the current stock quote, and if it exceeds the stock price they would invest in it.

Cash Per Share

 = 

Total Cash

Average Shares

More About Cash Per Share | All Equity Analysis

Current EGF Theramed Cash Per Share

    
  0.02 X  
Most of EGF Theramed's fundamental indicators, such as Cash Per Share, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, EGF Theramed Health is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Companies with high Cash per Share ratio will be considered as an attractive investment by most investors. In most industries if you can single out an equity instrument trading below its cash per share value, you have a bargain and should consider buying it. Finding the stocks traded below their cash value, therefore, can be a good starting point for investors using strategies based on fundamentals.
Competition

In accordance with the recently published financial statements, EGF Theramed Health has a Cash Per Share of 0.02 times. This is 99.54% lower than that of the Healthcare sector and significantly higher than that of the Health Information Services industry. The cash per share for all United States stocks is 99.6% higher than that of the company.

EGF Cash Per Share Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses EGF Theramed's direct or indirect competition against its Cash Per Share to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of EGF Theramed could also be used in its relative valuation, which is a method of valuing EGF Theramed by comparing valuation metrics of similar companies.
EGF Theramed is currently under evaluation in cash per share category among its peers.

EGF Fundamentals

About EGF Theramed Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze EGF Theramed Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of EGF Theramed using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of EGF Theramed Health based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

Other Information on Investing in EGF Pink Sheet

EGF Theramed financial ratios help investors to determine whether EGF Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in EGF with respect to the benefits of owning EGF Theramed security.